Annual long term liabilities:
$118.59M+$1.92M(+1.65%)Summary
- As of today (June 23, 2025), MDGL annual total long term liabilities is $118.59 million, with the most recent change of +$1.92 million (+1.65%) on December 31, 2024.
- During the last 3 years, MDGL annual long term liabilities has risen by +$118.20 million (+30542.64%).
- MDGL annual long term liabilities is now -3.37% below its all-time high of $122.72 million, reached on December 31, 2008.
Performance
MDGL Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$118.75M+$168.00K(+0.14%)Summary
- As of today (June 23, 2025), MDGL quarterly total long term liabilities is $118.75 million, with the most recent change of +$168.00 thousand (+0.14%) on March 31, 2025.
- Over the past year, MDGL quarterly long term liabilities has increased by +$1.57 million (+1.34%).
- MDGL quarterly long term liabilities is now -8.60% below its all-time high of $129.93 million, reached on March 31, 2009.
Performance
MDGL quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MDGL Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | +1.3% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | +10000.0% | +10000.0% |
MDGL Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | -3.4% | >+9999.0% | -8.6% | >+9999.0% |
MDGL Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $118.75M(+0.1%) |
| Dec 2024 | $118.59M(+1.6%) | $118.59M(+0.3%) |
| Sep 2024 | - | $118.26M(+0.6%) |
| Jun 2024 | - | $117.51M(+0.3%) |
| Mar 2024 | - | $117.18M(+0.4%) |
| Dec 2023 | $116.67M(+136.7%) | $116.67M(+0.5%) |
| Sep 2023 | - | $116.05M(+16.9%) |
| Jun 2023 | - | $99.25M(+18.2%) |
| Mar 2023 | - | $83.97M(+70.4%) |
| Dec 2022 | $49.29M(>+9900.0%) | $49.29M(+0.5%) |
| Sep 2022 | - | $49.05M(+0.4%) |
| Jun 2022 | - | $48.85M(>+9900.0%) |
| Mar 2022 | - | $283.00K(-26.9%) |
| Dec 2021 | $387.00K(-17.3%) | $387.00K(-21.2%) |
| Sep 2021 | - | $491.00K(-17.3%) |
| Jun 2021 | - | $594.00K(+53.5%) |
| Mar 2021 | - | $387.00K(-17.3%) |
| Dec 2020 | $468.00K(+29.6%) | $468.00K(-14.6%) |
| Sep 2020 | - | $548.00K(+178.2%) |
| Jun 2020 | - | $197.00K(-29.4%) |
| Mar 2020 | - | $279.00K(-22.7%) |
| Dec 2019 | $361.00K(>+9900.0%) | $361.00K(-18.1%) |
| Sep 2019 | - | $441.00K(-15.2%) |
| Jun 2019 | - | $520.00K(-13.0%) |
| Mar 2019 | - | $598.00K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00 | $0.00(-100.0%) |
| Sep 2015 | - | $11.00K(-65.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $32.00K(-98.6%) |
| Mar 2015 | - | $2.33M(-49.8%) |
| Dec 2014 | $4.65M(-66.6%) | $4.65M(-33.3%) |
| Sep 2014 | - | $6.97M(-24.9%) |
| Jun 2014 | - | $9.28M(-19.9%) |
| Mar 2014 | - | $11.60M(-16.6%) |
| Dec 2013 | $13.90M(+211.4%) | $13.90M(-13.7%) |
| Sep 2013 | - | $16.12M(-12.5%) |
| Jun 2013 | - | $18.42M(-10.4%) |
| Mar 2013 | - | $20.55M(+360.1%) |
| Dec 2012 | $4.46M(-64.0%) | $4.46M(-30.9%) |
| Sep 2012 | - | $6.46M(-23.5%) |
| Jun 2012 | - | $8.45M(-19.0%) |
| Mar 2012 | - | $10.43M(-15.9%) |
| Dec 2011 | $12.40M(-10.5%) | $12.40M(+1.9%) |
| Sep 2011 | - | $12.17M(-12.0%) |
| Jun 2011 | - | $13.84M(+10.6%) |
| Mar 2011 | - | $12.51M(-9.7%) |
| Dec 2010 | $13.85M(+84.0%) | $13.85M(-16.9%) |
| Sep 2010 | - | $16.67M(+250.0%) |
| Jun 2010 | - | $4.76M(-22.1%) |
| Mar 2010 | - | $6.12M(-18.8%) |
| Dec 2009 | $7.53M(-93.9%) | $7.53M(-16.0%) |
| Sep 2009 | - | $8.97M(-13.9%) |
| Jun 2009 | - | $10.41M(-92.0%) |
| Mar 2009 | - | $129.93M(+5.9%) |
| Dec 2008 | $122.72M(+59.4%) | $122.72M(+25.1%) |
| Sep 2008 | - | $98.14M(+28.2%) |
| Jun 2008 | - | $76.55M(+1.5%) |
| Mar 2008 | - | $75.39M(-2.1%) |
| Dec 2007 | $76.98M(+71.1%) | $76.98M(+2368.1%) |
| Sep 2007 | - | $3.12M(-4.6%) |
| Jun 2007 | - | $3.27M(-3.0%) |
| Mar 2007 | - | $3.37M(-92.5%) |
| Dec 2006 | $44.99M(+956.4%) | $44.99M(+1.2%) |
| Sep 2006 | - | $44.44M(+943.3%) |
| Dec 2005 | $4.26M(+258.5%) | $4.26M(+170.9%) |
| Mar 2005 | - | $1.57M |
| Dec 2004 | $1.19M(>+9900.0%) | - |
| Dec 2001 | $0.00 | - |
FAQ
- What is Madrigal Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual long term liabilities year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Madrigal Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of MDGL is $118.59M
What is the all time high annual long term liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total long term liabilities is $122.72M
What is Madrigal Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, MDGL annual total long term liabilities has changed by +$1.92M (+1.65%)
What is Madrigal Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of MDGL is $118.75M
What is the all time high quarterly long term liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total long term liabilities is $129.93M
What is Madrigal Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, MDGL quarterly total long term liabilities has changed by +$1.57M (+1.34%)